Inspire Medical Systems, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Inspire Upper Airway Stimulation (UAS) therapy for use in a subset of patients with moderate to severe Obstructive Sleep Apnea (OSA) who are unable to use Continuous Positive Airway Pressure (CPAP). Inspire therapy is a fully implanted neurostimulation device, the first of its kind for sleep apnea, that provides an alternative treatment that is proven, convenient and easy to use.
To view the Multimedia News Release, go to: http://www.multivu.com/mnr/7169651-fda-approves-inspire-upper-airway-stimulation-therapy-sleep-apnea
InComm, a leading provider of integrated technology solutions to retailers at point-of-sale (POS), announced the availability of its SIM card and no-contract wireless plan bundled into one Bring Your Own Device (BYOD) Starter Kit package. The InComm BYOD program was recently named a winner in the Best Choice Retail Card category in the 2015 Paybefore Awards.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7410151-incomm-byod-starter-kit/
Turning Device Seen on Lunar Module Miniature Model.
ALL NASA FOOTAGE USED IN THIS VIDEO IS PUBLIC DOMAIN. THE USE OF ANY COPYRIGHTED MATERIAL IS USED UNDER THE GUIDELINES OF "FAIR USE" IN TITLE 17 § 107 OF THE UNITED STATES CODE. SUCH MATERIAL REMAINS THE COPYRIGHT OF THE ORIGINAL HOLDER AND IS USED HERE FOR THE PURPOSES OF EDUCATION, COMPARISON, AND CRITICISM ONLY. NO INFRINGEMENT OF COPYRIGHT IS INTENDED.
Texas Instruments Incorporated (TI) (NYSE: TXN) today introduced the CC2567 device, the first wireless, single-chip solution that enables direct short-range communication between ultra low-power, ANT™+-enabled devices and commonly used mobile devices relying on Bluetooth® technology such as PCs, Smartphones and tablets. The industry’s first dual-mode device, the CC2567 requires 80 percent less board area than a design with two single-mode solutions (one ANT+, one Bluetooth), enables simultaneous operation over a shared antenna with built-in coexistence, and increases the wireless transmission range up to two times the distance of a single-mode ANT+ solution.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/texasinstruments/39160/
Callaway Golf Company (NYSE: ELY) today revealed its next generation golf GPS device, the Callaway upro mx. A successor to the Company’s acclaimed original upro device, which earned a Best of What’s New Award from Popular Science, the Callaway upro mx sets a new standard for innovation in the category with a host of intuitive
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/callawaygolf/46337/
GLO Science, LLC, introduces the GLO Brilliant™ Personal Teeth Whitening Device—available in Sephora stores nationwide and on Sephora.com—today, Thursday May 12. The Smile Revolution™ is here!
The GLO Brilliant™ Personal Teeth Whitening Device uses a patent-pending Guided Light Optics (GLO) technology for superior, at-home whitening results without sensitivity. GLO™ Whitening combines the innovative, patented GLO Brilliant™ Mouthpiece partnered with the unique G-Vial whitening gel delivery system to accelerate the whitening process. Now you can decide where, when, how long, and how often to whiten, without sensitivity. The payoff is teeth that are as white and bright as can be, simply put it on, press power—and GLO.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/glo/50090/
Nearly 200 years after the introduction of the stethoscope, the accuracy of a pocket ultrasound device that enables a physician to “look” at a patient’s heart during routine physical exams has been validated for the first time in peer-reviewed research led by Scripps Translational Science Institute (STSI) and Scripps Health.
Roughly the size of a smart phone, the Vscan™ pocket ultrasound used for point of care assessment of heart health could significantly reduce costs from traditional echocardiograms and improve the quality of care. Research was published in the July 5 issue of the Annals of Internal Medicine.
To view Multimedia News Release, go to http://www.multivu.com/mnr/50963-vscan-pocket-ultrasound-echocardiogram-stethoscope
CareFusion (NYSE: CFN), a leading global medical technology company, today announced the launch of the ReVel™ ventilator, a new high performance, portable device designed for pediatric to adult (min. 5Kg) patients who require breathing support during transport.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/carefusion/50615/
Based on its recent analysis of the biometrics market, Frost & Sullivan recognizes M2SYS with the 2011 North American Frost & Sullivan Award for New Product Innovation for its unique Hybrid Biometric Platform™, - the first scalable, multi-modal biometrics system that supports fingerprint, finger vein, palm vein, and iris recognition from a single server.
The biometric recognition domain lacks enterprise-ready, customizable, device-independent systems that allow organizations of any size to avoid being limited to one biometric modality or a single biometric device. M2SYS takes a giant leap with its innovative solution that works reliably and with a high success rate for all users.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/frostsullivan/52531/
Touch-screen technology is everywhere and it comes as no surprise that today’s children are practically born digital. It’s second nature for even the youngest children to pick up a smart device and instinctively navigate to find their favorite, age-appropriate apps. As parents try to help their children find a healthy balance between traditional and tech play, one thing is for certain…this growing trend isn’t slowing down any time soon.
In 2011, Fisher-Price, the leading maker of infant and preschool toys and Mattel’s largest brand, took an innovative approach to integrating “app-cessories” into its product line by creating the Laugh & Learn™ Apptivity™ Case for iPhone® and iPod® touch devices to protect parents’ coveted devices from babies’ dribble and drool. The Apptivity Case, appropriate for children ages six months+, was developed in conjunction with free Laugh & Learn apps to enable infants to experience their favorite Laugh & Learn characters, like the beloved Puppy, in a new, engaging format.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56836-fisher-price-laugh-learn-apps-toddlers-touch-screen-technology
EnteroMedics Inc. (NASDAQ: ETRM) today announced that the U.S. Food and Drug Administration (FDA) has approved VBLOC® vagal blocking therapy, delivered via the Maestro® System, for the treatment of adult patients with obesity who have a Body Mass Index (BMI) of at least 40 to 45 kg/m2, or a BMI of at least 35 to 39.9 kg/m2 with a related health condition such as high blood pressure or high cholesterol levels, and who have tried to lose weight in a supervised weight management program within the past five years. The Maestro System is the first new medical device to be approved by the FDA for obesity in over ten years. EnteroMedics anticipates that the device will be available, on a limited basis, at select Bariatric Centers of Excellence in the U.S. this year. The Maestro System has received CE Mark and is listed on the Australian Register of Therapeutic Goods.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7269351-enteromedics-fda-approval-vbloc-maestro-system-weight-loss-device/
